S

Synthetic Genomics

93 employees

Viridos develops genomic-driven solutions to address global energy and environmental challenges.

Investor insights

Sectors invested in

Metabolome Analysis1
Biotechnology1
Health Care1
Genetics1
Health Diagnostics1
Microbiome Sequencing1
Cancer Risk Assessments1
DNA Sequencing1
Whole Genome Sequencing1
Health Risk Assessments1
Executive Physicals1
RNA Sequencing1
Magnetic Resonance Imaging (MRI)1
Cancer Exome Sequencing1

Funding rounds participated in

$80M sweet spot round size

Most of their 1 investments are in rounds between $80M and $80M

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Bioprocessing
Cell Optimization
Algae
Fermentation
Algae Biofuels
Next Generation Genomics
Gene Editing
Scale-up
Biodiscovery
Synthetic Biology
Health Care
Cell Engineering
Medical
Renewable Energy
Advanced Engineering
Bioinformatics

Date founded

2005

Investments made

H

Human Longevity, Inc. raised $80M on March 4, 2014

Investors: Celgene, OS Fund and Synthetic Genomics

Funding rounds raised

Total raised

$50M

from 6 investors over 6 rounds

S

Synthetic Genomics raised $25M on March 13, 2023

Investors: Breakthrough Energy Ventures

S

Synthetic Genomics raised $50M on September 22, 2015

Investors: Lung Biotechnology PBC

S

Synthetic Genomics raised $50M on April 1, 2014

Investors: Lung Biotechnology PBC

S

Synthetic Genomics raised $35M on June 3, 2010

Investors: Excel Venture Management, LLC

S

Synthetic Genomics raised undisclosed on May 1, 2007

Investors: ACGT

S

Synthetic Genomics raised $30M on October 11, 2005

Investors: DFJ Frontier

FAQ